Inventor · disambiguated record
Lars Bärfacker
Also filed as: BAERFACKER LARS · BARFACKER LARS · Bärfacker Lars
29 granted patents·16 pending applications·170 citations·filing 2003–2023
95Inventor score
Top patents by PatentIndex Score
45 records- 0195US9216978B2Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseasesFOLLMANN MARKUS·Filed 2011·Granted Dec 22, 2015·35 cites·10 claims
- 0294US9096592B2Bicyclic aza heterocycles, and use thereofFOLLMANN MARKUS·Filed 2011·Granted Aug 4, 2015·28 cites·6 claims
- 0387US8436180B2Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereofBAERFACKER LARS·Filed 2008·Granted May 7, 2013·17 cites·10 claims
- 0486US8399471B2Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the sameFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 19, 2013·18 cites·6 claims
- 0581US8252817B2Dipyridyl-dihydropyrazolones and their useFLAMME INGO·Filed 2006·Granted Aug 28, 2012·7 cites·10 claims
- 0680US7687510B2Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processesBAYER HEALTHCARE AG·Filed 2003·Granted Mar 30, 2010·17 cites·23 claims
- 0779US7566723B21-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their useBAYER HEALTHCARE AG·Filed 2003·Granted Jul 28, 2009·14 cites·11 claims
- 0877US7691854B2Dihydropyridine derivatives for use as human neutrophil elastase inhibitorsBAYER SCHERING PHARMA AG·Filed 2003·Granted Apr 6, 2010·13 cites·17 claims
- 0976US9051316B2Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their useBAYER IP GMBH·Filed 2013·Granted Jun 9, 2015·3 cites·12 claims
- 1075US10370339B2N-Methylbenzimidazoles as mIDH1 inhibitorsBayer Pharma AG·Filed 2016·Granted Aug 6, 2019·2 cites·15 claims
- 1175US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 1274US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 1373US8143411B2Substituted 6-phenylnicotinic acids and their useBAERFACKER LARS·Filed 2008·Granted Mar 27, 2012·2 cites·7 claims
- 1472US9370517B2Substituted pyrazolopyrimidines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Jun 21, 2016·2 cites·8 claims
- 1569US8183246B2Acyclically substituted furopyrimidine derivatives and use thereofLAMPE THOMAS·Filed 2006·Granted May 22, 2012·1 cites·9 claims
- 1667US9206185B2Imidazopyridazines as Akt kinase inhibitorsBärfacker Lars·Filed 2012·Granted Dec 8, 2015·2 cites·39 claims
- 1767US9085572B24-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseasesFLAMME INGO·Filed 2012·Granted Jul 21, 2015·1 cites·6 claims
- 1867US7230017B2Dihydropyridinone derivativesBAYER HEALTHCARE AG·Filed 2003·Granted Jun 12, 2007·4 cites·17 claims
- 1966US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 2063US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 2161US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2255US8173665B2I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their useGIELEN-HAERTWIG HEIKE·Filed 2009·Granted May 8, 2012·0 cites·12 claims
- 2355US2023201174A1Combination of finerenone and a sglt2 inhibitor for the treatment and/or prevention of cardiovascular and/or renal diseasesBAYER AG·Filed 2021·Application pending·0 cites
- 2451US2010099681A1Substituted 5-aminopyrazoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2550US2011183928A13-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2647US9682995B2Amino-substituted isothiazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·0 cites·15 claims
- 2746US2010298221A12-phenoxy nicotine acid derivative and use thereofBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 2845US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2944US8404709B2Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereofFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 26, 2013·0 cites·5 claims
- 3044US8324222B2Cyclically substituted furopyrimidine derivatives and use thereofLAMPE THOMAS·Filed 2006·Granted Dec 4, 2012·0 cites·8 claims
- 3143US9604989B2Imidazopyridazines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2015·Granted Mar 28, 2017·0 cites·6 claims
- 3243US7498460B2Isophthalic acid derivativesBAYER HEALTHCARE AG·Filed 2003·Granted Mar 3, 2009·0 cites·9 claims
- 3342US9260435B2Substituted imidazopyrazines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Feb 16, 2016·0 cites·8 claims
- 3442US2008194598A1Pyrimidine Carboxylic Acid Derivatives and Use ThereofBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3541US2008176898A1Phenyl AcetamidesBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3640US8404723B23-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseasesBARFACKER LARS·Filed 2007·Granted Mar 26, 2013·0 cites·5 claims
- 3740US2008261990A1Novel Pyrimidine Derivatives and their UseBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3838US2008255202A1Phenylthioacetic Acid Derivatives and Use ThereofBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3935US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4035US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4135US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4233US10428044B23-amino-1,5,6,7-tetrahydro-4H-indol-4-onesBayer Pharma AG·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
- 4333US2017217946A1Amino-substituted isoxazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4432US2017334899A1Amino-substituted isothiazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 4531US10047096B2Substituted pyridobenzodiazepinone-derivatives and use thereofBayer Pharma AG·Filed 2015·Granted Aug 14, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Lars Bärfacker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →